A major advance in cancer research is occurring with the use of mini-antibodies to reactivate dysfunctional p53. This essential malignant protector protein is frequently disabled in many kinds of cancer, causing https://ragingbookmarks.com/story21958708/nanobodies-restore-the-p53-protein-a-new-approach-for-tumor-treatment